Rapilif D 4/0.5 Capsule

Prescription Required

10 Capsule
₹250.00₹280.50

Storage

Store below 30°C

Only 3 quantities left in stock.
Product Highlights / Product Specification and Features
  • Rapilif D 4/0.5 Capsule is used in the prevention of Benign prostatic hyperplasia.
  • Rapilif D 4/0.5 Capsule prevents symptoms like urgent urination.
  • Details
  • Benefits
  • Side effects

Rapilif D 4/0.5 Capsule is a medication combination used to treat the symptoms of benign prostatic hyperplasia (BPH) in people who have an enlarged prostate gland. Rapilif D 4/0.5 Capsule helps in the relief of symptoms such as trouble peeing or the need to urinate more frequently, as well as the improvement of your capacity to urinate. A small, muscular gland, the prostate is a part of the male reproductive system. BPH refers to prostate enlargement, which is a prevalent disorder in males between the ages of 50 and 60. It happens when the prostate gland's cells begin to proliferate. The bladder wall thickens with an enlarged prostate gland, and the bladder may weaken and lose its capacity to empty completely, leaving some pee in the bladder.

Usage instructions-

  • The dose and duration of Rapilif D 4/0.5 Capsule should be taken as directed by your doctor.

How it works-

Adults with an enlarged prostate gland may be treated for the symptoms of benign prostatic hyperplasia (BPH) with Rapilif D 4/0.5 Capsule, a combination of dutasteride and silodosin. Silodosin is a member of a class of alpha-1 receptor blockers, which are found in the bladder and prostate. By preventing the activation of alpha-1 receptors, silodosin relaxes the smooth muscles in the bladder and prostate. Dutasteride is a member of the 5-alpha reductase class of medications that reduces the size of the prostate gland by inhibiting the activity of a 5-alpha reductase enzyme. Taking Rapilif D 4/0.5 Capsule helps you urinate more easily and lessens the symptoms of BPH.

Safety information-

Pregnancy

There are no instructions found in terms of pregnancy. You should consult your doctor.

Breastfeeding

There are no instructions found in this case. You should consult your doctor.

Alcohol

It may cause excessive drowsiness to consume alcohol with Rapilif D 4/0.5 Capsule.

Driving

Rapilif D 4/0.5 Capsule may impair your alertness, impair your eyesight, or make you drowsy and dizzy. If you have any of these symptoms, do not drive.

Kidney

Rapilif D 4/0.5 Capsule should be administered with caution to patients with kidney disease. Dose adjustments may be necessary. Please consult your doctor.

Liver

Rapilif D 4/0.5 Capsule should be administered with caution to patients with liver issues. Dose adjustments may be necessary. Please consult your doctor.

Disclaimer:

To the best of our ability, the data presented here is accurate and trustworthy because it has been professionally reviewed before publication. This information may not address all clinical and non-clinical aspects completely and is provided solely for informational purposes. This information should not be used to diagnose, manage, or prevent health problems. Nothing on this page is intended to establish a doctor-patient relationship or to substitute for a certified medical practitioner’s medical advice or consultation.

Manufacturer/Marketer :

Ipca laboratories ltd

125, Kandivli Industrial Estate, Kandivli (West), Mumbai – 400 067, Maharashtra, India

Country of origin: India

Expires on or after: November 30, 2025

Whatsapp Us

+917088068006

Download the app now!

play-store-icon
reliable-icon

Reliable

All products displayed on Rigmeds are procured from verified and licensed pharmacies. All labs listed on the platform are accredited.

secure-icon

Secure

Rigmeds uses Secure Sockets Layer (SSL) 128-bit encryption and is Payment Card Industry Data Security Standard (PCI DSS) compliant.

affordable-icon

Affordable

Find affordable medicine substitutes, save up to 50% on health products.

master-cardvisa-paymentg-payphone-paypaytmUPI-payment
© Copyright 2025 Rigmeds All rights reserved
All medications are distributed in accordance with the Drugs and Cosmetics Act of 1940 and the Drugs and Cosmetics Rules of 1945. We do not processed requests for Schedule X and habit-forming medicines.